We drive innovation by focusing on the areas that matter most to the future of health. These areas are advanced gene therapies and regenerative medicine, viral and infectious diseases, diagnostics and technological innovation, and prevention and lifestyle, with data & AI as a cross-cutting theme.
By strengthening local communities step by step, we aim to create centers of excellence that not only facilitate knowledge exchange and spur new collaborations and innovations but also enhance coalition building, attract external funding, and draw talent recognized for their impact in these focus areas.
Regenerative medicine
We drive regenerative medicine forward, uniting LUMC, J&J, NECSTGen, Galapagos, and Bristol Myers Squibb to advance tissue engineering, stem cell therapies, and gene therapies. With state-of-the-art facilities and a collaborative ecosystem, we accelerate the development and production of these therapies, offering new hope to patients worldwide.
Precision medicine & diagnostics
Precision medicine and diagnostics are reshaping healthcare by tailoring treatments to genetic and biomarker profiles, improving outcomes and minimizing side effects. Key players like Mimetas, DC Prime, ProQR Therapeutics, VitroScan, and Toxys lead the way with innovations in organ-on-a-chip technology, cancer vaccines, RNA therapies, and advanced screening solutions.
Prevention & lifestyle
We are reshaping the future of health, emphasizing proactive care over reactive treatments. Leaders like the Leiden Healthy Society Center, TNO, and LUMC are advancing public health through research, digital health solutions, and scalable interventions that tackle lifestyle-related challenges.
Vaccines & infectious disease
Collaboration is key to addressing global health challenges, and to advance vaccine development and pandemic preparedness. Organizations like Batavia Biosciences optimize scalable vaccine production, J&J Innovative Medicine demonstrates rapid response capabilities with projects like the Janssen COVID-19 vaccine, and LUMC drives infectious disease research.
AI & data science
AI and data science innovation from leaders like LIACS, Imuno Therapeutics, and LUMC’s CAIRELab drive advancements to accelerate drug discovery, improve patient care, and enable faster transitions from research to real-world applications, reshaping the future of health across all scientific themes.
Join the future of health
The focus on innovation and valorization at Leiden Bio Science Park means that new scientific knowledge continually translates into societal and economic benefits. This proactive approach not only fosters health and technology advancements but also strengthens the park’s reputation as a leader in scientific entrepreneurship.
Join the innovation revolution at Leiden Bio Science Park. Whether you are a researcher, entrepreneur, or industry professional, explore how you can be part of our dynamic ecosystem and turn pioneering ideas into valuable outcomes. Do you want to explore the diverse companies and organizations working on the future of health? Search the interactive map and explore everything at the park.
Regenerative
medicine
We drive regenerative medicine forward, uniting LUMC, J&J, NECSTGen, Galapagos, and Bristol Myers Squibb to advance tissue engineering, stem cell therapies, and gene therapies. With state-of-the-art facilities and a collaborative ecosystem, we accelerate the development and production of these therapies, offering new hope to patients worldwide.
Precision medicine & diagnostics
Precision medicine and diagnostics are reshaping healthcare by tailoring treatments to genetic and biomarker profiles, improving outcomes and minimizing side effects. Key players like Mimetas, DC Prime, ProQR Therapeutics, VitroScan, and Toxys lead the way with innovations in organ-on-a-chip technology, cancer vaccines, RNA therapies, and advanced screening solutions.
Prevention & lifestyle
We are reshaping the future of health, emphasizing proactive care over reactive treatments. Leaders like the Leiden Healthy Society Center, TNO, and LUMC are advancing public health through research, digital health solutions, and scalable interventions that tackle lifestyle-related challenges.
Vaccines & infectious disease
Collaboration is key to addressing global health challenges, and to advance vaccine development and pandemic preparedness. Organizations like Batavia Biosciences optimize scalable vaccine production, J&J Innovative Medicine demonstrates rapid response capabilities with projects like the Janssen COVID-19 vaccine, and LUMC drives infectious disease research.
AI & data science
AI and data science innovation from leaders like LIACS, Imuno Therapeutics, and LUMC’s CAIRELab drive advancements to accelerate drug discovery, improve patient care, and enable faster transitions from research to real-world applications, reshaping the future of health across all scientific themes.
Join the future of health
The focus on innovation and valorization at Leiden Bio Science Park means that new scientific knowledge continually translates into societal and economic benefits. This proactive approach not only fosters health and technology advancements but also strengthens the park’s reputation as a leader in scientific entrepreneurship.
Join the innovation revolution at Leiden Bio Science Park. Whether you are a researcher, entrepreneur, or industry professional, explore how you can be part of our dynamic ecosystem and turn pioneering ideas into valuable outcomes. Do you want to explore the diverse companies and organizations working on the future of health? Search the interactive map and explore everything at the park.
Liesbeth Veugen
Liesbeth works at the University of Leiden while also fulfilling a role at the Leiden Bio Science Park, closing the gap between public and private partners to strengthen innovations within the life science and health sector. Are you bringing your innovation to the market, or are you in need of fundamental insights? Liesbeth is happy to support your thought process.